For harm reduction purposes, could co administration of Cannabis with a gabergic sedative such as Alparazolam decrease the psychotomimetic effects of marijuana for someone who currently has schizophrenia? From what I know, this illness is caused by decreased GABA levels, glutaminergic hypofunction, and dopamine hyperfunction. Gabergic sedatives are known to decrease paranoia and anxiety in individuals susceptible to said phenomenon. And if this administration works, could this also be extrapolated to usage of dopaminergic stimulants such as psilocybin or methamphetamine? Personal anecdotes and/or publications are needed.